Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial.

Autor: Grainger, John D.1,2 john.grainger@cmft.nhs.uk, Locatelli, Franco3, Chotsampancharoen, Thirachit4, Donyush, Elena5, Pongtanakul, Bunchoo6, Komvilaisak, Patcharee7, Sosothikul, Darintr8, Drelichman, Guillermo9, Sirachainan, Nongnuch10, Holzhauer, Susanne11, Lebedev, Vladimir12, Lemons, Richard13, Pospisilova, Dagmar14, Ramenghi, Ugo15, Bussel, James B.16, Bakshi, Kalpana K.17, Iyengar, Malini17, Chan, Geoffrey W.17, Chagin, Karen D.17, Theodore, Dickens18
Zdroj: Lancet. 10/24/2015, Vol. 386 Issue 10004, p1649-1658. 10p. 1 Diagram, 7 Charts, 2 Graphs.
Databáze: Business Source Ultimate